Jenner Institute

On Thursday, Nigeria announced the rollout of the R21 malaria vaccine co-developed by Jenner Institute, Serum Institute of India Pvt. Ltd. and Novavax. This marks a significant milestone in the country's fight against the deadly disease. Find out more 👉 https://lnkd.in/eStJCy_9

We are very proud of Mehreen Datoo, a Jenner Institute Clinical research fellow who has been named on the TIME100 Next list for her work on progressing the R21/Matrix-M malaria vaccine. The vaccine, developed by the Jenner Institute, University of Oxford, was recommended for use by the World Health Organization and started roll-out in July this year. The TIME100 Next list spotlights 100 rising stars who are shaping the future of business, entertainment, sports, politics, science, health and more. Congratulations Mehreen! 🌟 #malaria #vaccine #R21 #TIME100 https://lnkd.in/efx6cWyQ

HAVE WE BEATEN MALARIA? 🦟🧬💉🧫🥼 More than half a million people die of #malaria every year. With 2 #vaccines recommended for use, Lisa Stockdale and Andrew Duncan from the University of Oxford will discuss what the prospects are for eliminating malaria and how long it might take. Join them on 11th September at https://lnkd.in/echp57mD #SMLATES

Yesterday, the new R21/Matrix-M™ malaria vaccine was rolled out in Côte d'Ivoire, which became the first country to vaccinate a child in Abidjan. This is a first critical step in the global fight against malaria. Between 2024 and 2025, 6.6 million children are expected to be vaccinated in 15 African countries with the support of Gavi, the Vaccine Alliance. R21/Matrix-M™ was co-developed by the Jenner Institute at the University of Oxford and Serum Institute of India Pvt. Ltd. using Novavax’s Matrix-M™ adjuvant. Serum Institute of India Pvt. Ltd. is committed to scaling up to 100 million doses annually in the future. #malaria #vaccine #R21 https://lnkd.in/gsQZjUUM

Congratulations to Prof Alexander (Sandy) Douglas and the team from the Jenner Institute and AstraZeneca for being the runners-up for the 2024 MacRobert Award from the Royal Academy of Engineering for their engineering innovation in the manufacturing of the COVID vaccine. Find out more 👉 https://lnkd.in/eRbMvFcZ

The Hill Group at the Jenner Institute, Nuffield Department of Medicine is seeking a Programme Manager, with responsibility for  providing management support to a range of pre-clinical and translational projects led by Professor Hill. The group’s translational activity is underpinned by a strong programme of preclinical work, seeking to identify new vaccine targets, and to design and validate future generations of vaccines. Previously, our principal focus has been upon the development of malaria vaccines using replication-deficient viral vector platforms. More recently, we have developed a virus-like particle approach, which is currently undergoing clinical evaluation. For more information, please visit: https://lnkd.in/etJSuwck The main responsibilities of this role will be to undertake the financial management of the Hill group portfolio of pre-clinical and translational grant funding including approving requisitions and financial reporting, as well as being responsible for the strategic management of the novel Rvx21 clinical trials in locations such as the UK, Thailand and Indonesia, including financial management, coordination of sites, regulatory approvals and overall Project coordination. For more information on this exciting opportunity, please see the link below; https://lnkd.in/ePe_cp_S #programmemanager #malariavaccine #oxforduniversity #wearehiring

I am pleased to announce that we are recruiting for a 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐚𝐬𝐬𝐢𝐬𝐭𝐚𝐧𝐭. Apply if the role is for you!  For more information: https://lnkd.in/edB-_5ic

Some exciting opportunities to work with Jenner Institute researchers at University of Oxford on #malaria #vaccines 1. Research Assistant on #R21 malaria vaccine immunology - https://lnkd.in/eiT5DHh9 2. Research Assistant on second generation malaria vaccines - https://lnkd.in/eR-DuWnn 3. Research Assistant in Malaria Vaccine Genetics - https://lnkd.in/e55kmW48

Some exciting opportunities to work with Jenner Institute researchers at University of Oxford on #malaria #vaccines 1. Research Assistant on #R21 malaria vaccine immunology - https://lnkd.in/eiT5DHh9 2. Research Assistant on second generation malaria vaccines - https://lnkd.in/eR-DuWnn 3. Research Assistant in Malaria Vaccine Genetics - https://lnkd.in/e55kmW48

Happy to share a review that we recently got published! This review highlights the significant contributions of the evolving mRNA vaccine technology and its potential applications within the One Health framework. My vision is that in the next 10-15 years, mRNA vaccines shall play a transformative role in combating tick-borne diseases and other arthropod-borne pathogens, which are critical for both human and animal health. The review emphasises the urgent need for ongoing research and innovation to overcome current challenges and enhance the feasibility of these vaccines for broader use. As we continue to advance technologically, the prospect of utilising mRNA vaccines in veterinary medicine is increasingly promising. These advancements could lead to widespread implementation, delivering substantial public health and environmental benefits, and reinforcing the pivotal role of mRNA vaccines in future human health strategies. Congrats to Elizabeth Gonzalez Cueto and thanks to Prof Jose de la fuente for maintaining an active collaboration. Bill & Melinda Gates Foundation Jenner Institute Nuffield Department of Medicine